← Every applicant
Laurus FDA Approvals
18 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| TICAGRELORNew drugAug 20, 2026TABLET, ORAL |
| RILPIVIRINE HYDROCHLORIDENew drugJul 10, 2026TABLET, ORAL |
| VALSARTANNew drugApr 21, 2026TABLET, ORAL |
| EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATENew drugMar 4, 2026TABLET, ORAL |
| MACITENTANNew drugNov 5, 2025TABLET, ORAL |
| FLUCYTOSINENew drugJul 23, 2025CAPSULE, ORAL |
| SACUBITRIL AND VALSARTANNew drugMay 28, 2024TABLET, ORAL |
| OSELTAMIVIR PHOSPHATENew drugMay 1, 2024CAPSULE, ORAL |
| GABAPENTINNew drugApr 8, 2024TABLET, ORAL |
| ATORVASTATIN CALCIUMNew drugJan 22, 2024TABLET, ORAL |
| METFORMIN HYDROCHLORIDENew drugOct 5, 2023TABLET, EXTENDED RELEASE, ORAL |
| GABAPENTINNew drugMay 12, 2023CAPSULE, ORAL |
| ABACAVIR SULFATE AND LAMIVUDINENew drugJul 25, 2022TABLET, ORAL |
| PIRFENIDONENew drugJul 19, 2022CAPSULE, ORAL |
| PIRFENIDONENew drugJul 19, 2022TABLET, ORAL |
| LOPINAVIR AND RITONAVIRNew drugMar 21, 2022TABLET, ORAL |
| EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATENew drugDec 22, 2021TABLET, ORAL |
| ATAZANAVIR SULFATENew drugApr 30, 2021CAPSULE, ORAL |